{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 encodes a kinase that is implicated in the pathogenesis of Parkinson’s disease (PD). The paper describes LRRK2 as encoding a kinase involved in the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that LRRK2 encodes a kinase and is implicated in the pathogenesis of PD.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "Yes",
          "reasoning": "The assay (enzyme activity assay) effectively models the defined disease mechanism as LRRK2 is a kinase, and activity changes reflect potential pathogenic/benign effects.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "No",
          "reasoning": "While the assay describes differences in activity compared to “wild type,” explicit details regarding other relevant controls (positive and negative) are missing.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "N/A",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state the assay's widespread acceptance or prior validation in other studies.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "overall_judgment": {
        "functional_evidence_strength": "Max PS3_supporting",
        "reasoning": "Due to the lack of both clear controls and validation, the variant's effect is deemed PS3_supporting"
      }
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "A",
          "position": "1628"
        },
        "variant_string_id": "LRRK2 R1628A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 encodes a kinase that is implicated in the pathogenesis of Parkinson’s disease (PD). The paper describes LRRK2 as encoding a kinase involved in the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that LRRK2 encodes a kinase and is implicated in the pathogenesis of PD.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "Yes",
          "reasoning": "The assay (enzyme activity assay) effectively models the defined disease mechanism as LRRK2 is a kinase, and activity changes reflect potential pathogenic/benign effects.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "No",
          "reasoning": "While the assay describes differences in activity compared to “wild type,” explicit details regarding other relevant controls (positive and negative) are missing.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "N/A",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state the assay's widespread acceptance or prior validation in other studies.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "overall_judgment": {
        "functional_evidence_strength": "Max PS3_supporting",
        "reasoning": "Due to the lack of both clear controls and validation, the variant's effect is deemed PS3_supporting"
      }
    }
  ]
}